New Zealand markets close in 6 hours 40 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
123.64-0.68 (-0.55%)
At close: 04:00PM EDT
123.45 -0.19 (-0.15%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 48.37B
Enterprise value 41.36B
Trailing P/E 3.76
Forward P/E 21.60
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.37
Price/book (mrq)2.69
Enterprise value/revenue 1.86
Enterprise value/EBITDA 2.59

Trading information

Stock price history

Beta (5Y monthly) 1.69
52-week change 3-69.76%
S&P500 52-week change 3-16.88%
52-week high 3434.00
52-week low 3115.61
50-day moving average 3152.35
200-day moving average 3164.60

Share statistics

Avg vol (3-month) 34.86M
Avg vol (10-day) 35.95M
Shares outstanding 5391.2M
Implied shares outstanding 6N/A
Float 8353.59M
% held by insiders 19.55%
% held by institutions 164.12%
Shares short (30 Aug 2022) 415.21M
Short ratio (30 Aug 2022) 43.19
Short % of float (30 Aug 2022) 45.24%
Short % of shares outstanding (30 Aug 2022) 43.89%
Shares short (prior month 28 Jul 2022) 414.73M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 61.12%
Operating margin (ttm)68.02%

Management effectiveness

Return on assets (ttm)46.34%
Return on equity (ttm)113.86%

Income statement

Revenue (ttm)22.99B
Revenue per share (ttm)57.20
Quarterly revenue growth (yoy)9.10%
Gross profit (ttm)13.86B
Net income avi to common (ttm)14.06B
Diluted EPS (ttm)32.29
Quarterly earnings growth (yoy)-21.00%

Balance sheet

Total cash (mrq)7.9B
Total cash per share (mrq)20.19
Total debt (mrq)887M
Total debt/equity (mrq)4.93
Current ratio (mrq)1.99
Book value per share (mrq)45.88

Cash flow statement

Operating cash flow (ttm)9.65B
Levered free cash flow (ttm)5.1B